Urologix (ULGX) Stock Price, News & Analysis

Company Overview

Urologix, Inc. was a medical device company focused on developing and marketing minimally invasive treatments for urological conditions, particularly benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

The company’s product portfolio included the Cooled ThermoTherapy system and the Prostiva RF Therapy system. These technologies were designed to use controlled thermal or radiofrequency energy to treat prostate tissue and relieve urinary symptoms associated with BPH, offering alternatives to more invasive surgical procedures.

Urologix marketed its products primarily through urology practices, hospitals and distributors in the United States and select international markets. Publicly available information about the company’s current operations and leadership is limited, and the business has primarily been documented through its historical medical-device activities.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 60 shs
• Average Volume: 1,001 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/15/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:ULGX
• CIK: 882873
• Web: www.urologix.com
• Phone: (763) 475-1400
• Fax: 763-404-8118
• Employees: 61
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -39.21